Jing Y - Search Results

1

Adverse events associated with potential drugs for COVID-19: a case study from real-world data.

Jing Y, Diao L, Han L. Jing Y, et al. Brief Bioinform. 2021 Mar 22;22(2):1232-1238. doi: 10.1093/bib/bbaa234. Brief Bioinform. 2021. PMID: 33003194 Free PMC article.

2

Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines.

Ruan H, Xiang Y, Ko J, Li S, Jing Y, Zhu X, Ye Y, Zhang Z, Mills T, Feng J, Liu CJ, Jing J, Cao J, Zhou B, Wang L, Zhou Y, Lin C, Guo AY, Chen X, Diao L, Li W, Chen Z, He X, Mills GB, Blackburn MR, Han L. Ruan H, et al. Among authors: jing y, jing j. Genome Med. 2019 Aug 26;11(1):55. doi: 10.1186/s13073-019-0663-5. Genome Med. 2019. PMID: 31446897 Free PMC article.

3

APAatlas: decoding alternative polyadenylation across human tissues.

Hong W, Ruan H, Zhang Z, Ye Y, Liu Y, Li S, Jing Y, Zhang H, Diao L, Liang H, Han L. Hong W, et al. Among authors: jing y. Nucleic Acids Res. 2020 Jan 8;48(D1):D34-D39. doi: 10.1093/nar/gkz876. Nucleic Acids Res. 2020. PMID: 31586392 Free PMC article.

4

Sex-associated molecular differences for cancer immunotherapy.

Ye Y, Jing Y, Li L, Mills GB, Diao L, Liu H, Han L. Ye Y, et al. Among authors: jing y. Nat Commun. 2020 Apr 14;11(1):1779. doi: 10.1038/s41467-020-15679-x. Nat Commun. 2020. PMID: 32286310 Free PMC article.

5

The genetic and pharmacogenomic landscape of snoRNAs in human cancer.

Liu Y, Ruan H, Li S, Ye Y, Hong W, Gong J, Zhang Z, Jing Y, Zhang X, Diao L, Han L. Liu Y, et al. Among authors: jing y. Mol Cancer. 2020 Jun 23;19(1):108. doi: 10.1186/s12943-020-01228-z. Mol Cancer. 2020. PMID: 32576192 Free PMC article.

6

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy.

Jing Y, Liu J, Ye Y, Pan L, Deng H, Wang Y, Yang Y, Diao L, Lin SH, Mills GB, Zhuang G, Xue X, Han L. Jing Y, et al. Nat Commun. 2020 Oct 2;11(1):4946. doi: 10.1038/s41467-020-18742-9. Nat Commun. 2020. PMID: 33009409 Free PMC article.

7

HeRA: an atlas of enhancer RNAs across human tissues.

Zhang Z, Hong W, Ruan H, Jing Y, Li S, Liu Y, Wang J, Li W, Diao L, Han L. Zhang Z, et al. Among authors: jing y. Nucleic Acids Res. 2021 Jan 8;49(D1):D932-D938. doi: 10.1093/nar/gkaa940. Nucleic Acids Res. 2021. PMID: 33119754 Free PMC article.

8

Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors.

Zhang Z, Jing J, Ye Y, Chen Z, Jing Y, Li S, Hong W, Ruan H, Liu Y, Hu Q, Wang J, Li W, Lin C, Diao L, Zhou Y, Han L. Zhang Z, et al. Among authors: jing y, jing j. Genome Med. 2020 Nov 23;12(1):101. doi: 10.1186/s13073-020-00795-6. Genome Med. 2020. PMID: 33225964 Free PMC article.

9

Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy.

Jing Y, Zhang Y, Wang J, Li K, Chen X, Heng J, Gao Q, Ye Y, Zhang Z, Liu Y, Lou Y, Lin SH, Diao L, Liu H, Chen X, Mills GB, Han L. Jing Y, et al. J Natl Cancer Inst. 2021 Oct 1;113(10):1396-1404. doi: 10.1093/jnci/djab035. J Natl Cancer Inst. 2021. PMID: 33705549

10

Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicity.

Jing Y, Liu Y, Li Q, Ye Y, Diao L, Huang Y, Zhou Y, Green MR, Mills GB, Han L. Jing Y, et al. Cancer Cell. 2021 Dec 13;39(12):1558-1559. doi: 10.1016/j.ccell.2021.09.016. Epub 2021 Oct 21. Cancer Cell. 2021. PMID: 34678153 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,318 results

Search Page

Filters